Keywords
Hearing loss
Disease activity
DAS 28
Categories
How to Cite
Abstract
Objectives: Rheumatoid arthritis (RA) is well known to affect many different organ systems. Previous work suggests that this includes the auditory system. The objectives of this work are to evaluate the pattern of hearing impairment in patients with rheumatoid arthritis and also to examine the possible associations between hearing impairment and related RA features especially disease activity.
Materials and methods: Thirty RA patients (mean age of 44.5 ± 9.9 years; female sex (90%)) and 17 healthy controls (mean age of 41.5±9.1 years; female sex (76.4%)) were included in our study. The 2 groups were matched for age and sex (p>0.05). The otoscopic examination was normal in all participants. No subject of the 2 groups has had any abnormalities at the otoscopic examination. Hearing impairment was evaluated by pure tone audiometry and tympanometry including static compliance, middle ear pressure, stapedial reflex threshold test. In all patients, the clinical features, laboratory data, X-rays, disease activity index-DAS 28 were performed.
Results: Hearing loss was more prevalent in RA patients compared to healthy controls (56.7 vs 11.8%; p=0.005). RA patients have conductive, sensorineural, and mixed hearing loss in respectively 43.4, 3.3, and 10 % of cases. Association analysis between hearing characteristics and remission in RA patients shows that RA patients in remission have significantly lower mean hearing thresholds (12.8±5.2dB vs 18.8±6.9 dB; p=0.04).
Conclusion: This study suggests that hearing loss risk is higher in RA patients and seems to be associated with disease duration. Hearing loss in RA was directly proportional to the disease activity index-DAS 28. An audiological evaluation must be performed periodically to identify possible audiological damage.
References
Seçkin U, Ozoran K, Ikinciogulları A, Borman P, Bostan E. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. Rheumatol Int. 2000; 19 (5):203-4. https://doi.org/10.1007/s002960000054
Kastaniodakis I, Skevas A, Daniellidis V, Tsiakou E, Drosos A, Moustopoulos MH. Inner ear involvement in rheumatoid arthritis: A prospective clinical study. J Laryngol Otol. 1995; 109(8):713-8. https://doi.org/10.1017/s0022215100131135
Rigual NR: Otolaryngologic manifestations of rheumatoid arthritis. Ear Nose Throat J. 1987 Nov; 66(11):436-9.
Ozcan M, Karakuş MF, Gündüz OH, Tuncel U, Sahin H. Hearing loss and middle ear involvement in rheumatoid arthritis. Rheumatol Int. 2002 May; 22 (1):16-9. https://doi.org/10.1007/s00296-002-0185-z
Raut V V, Cullen J, Cathers G. Hearing loss in rheumatoid arthritis. J Otolaryngol. 2001; 30 (5): 289–94. https://doi.org/10.1007/s00296-002-0185-z
Colletti V, Florino FG, Bruni L, Biasi D. Middle ear mechanics in subjects with rheumatoid arthritis. Audiology. 1997; 36(3):136-46. https://doi.org/10.3109/00206099709071967
Frade C, Martin C. Diagnostic value of the multifrequency tympanometry in active rheumatoid arthritis. Auris Nasus Larynx. 1998 May; 25(2):131-6. https://doi.org/10.1016/s0385-8146(98)00020-0
Siamopoulou-Mavridou A, Asimakopoulos D, Mavridis A, Skevas A, Moutsopoulos HM. Middle ear function in patients with juvenile chronic arthritis. Ann Rheum Dis. 1990 Aug; 49:620-3. https://doi.org/10.1136/ard.49.8.620
Elwany S, El-Garf A, Kamel T. Hearing and middle ear function in rheumatoid arthritis. J Rheumatol. 1986 Oct; 13(5): 878-81.
Takatsu M, Higaki M, Kinoshita H, Mizushima Y, Koizuka I. Ear involvement in patients with rheumatoid arthritis. Otol Neurotol. 2005 Jul; 26(4):755–61. https://doi.org/10.1097/01.mao.0000178138.19848.bd
Garcia Callejo FJ, Tobıas N C, Fernandez MN, Paula Vernetta C, Castañeira, Algarra JM. [Hearing impairment in patients with rheumatoid arthritis ]. Acta Otorrinolaringologica Esp. Jun-Jul 2007; 58(6): 232–238. https://doi.org/10.1016/S2173-5735(07)70341-1
Oztürk A, Yalçin S, ¸ Kaygusuz I, Sahin S, Gök U, Karlidağ T. High-Frequency Hearing Loss and Middle Ear Involvement in Rheumatoid Arthritis. Am J Otolaryngol. Nov-Dec 2004; 25 (6): 411-7. https://doi.org/10.1016/j.amjoto.2004.06.001
Pascual-Ramos V, Contreras-Yáñez I, Enríquez L, Valdés S, Ramírez-Anguiano J. hearing impairment in a tertiarycare-level population of Mexican rheumatoid arthritis patients. J Clin Rheumatol. 2012 Dec; 18 (8): 393-8. https://doi.org/10.1097/rhu.0b013e31827732d3
Coutinho MB, Duarte I. Hydroxychloroquineototoxicity in a child with idiopathic pulmonary haemosiderosis. Int J Pediatr Otorhinolaryngol. 2002 Jan 11; 62(1):53-57. https://doi.org/10.1016/s0165-5876(01)00592-4
Halligan CS, Bauch CD, Brey RH, Achenbach SJ, Bamlet WR, McDonald TJ, et al. Hearing loss in rheumatoid arthritis. Laryngoscope. 2006 Nov; 116(11): 2044-9. https://doi.org/10.1097/01.mlg.0000241365.54017.32
Salvinelli F, Cancilleri F, Casale M, Luccarelli V, Di Peco V, D'Ascanio L, et al. “Hearing thresholds in patients affected by rheumatoid arthritis,” Clin Otolaryngol Allied Sci. 2004 Feb; 29(1):75-9. https://doi.org/10.1111/j.1365-2273.2004.00783.x
Magaro M, Zoli A, Altomonte L, Mirone L, Corvino G, Di Girolamo S, et al. Sensorineural hearing loss in rheumatoid arthritis. Clin Exp Rheumatol. Sep-Oct 1990; 8(5):487–90.
Pascual-Ramos V, Contreras-Yáñez I, Rivera-Hoyos P, Enríquez L, Ramírez-Anguiano J. Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA). Clin Rheumatol. 2014 Mar; 33(3):315-21. https://doi.org/10.1007/s10067-014-2485-6
Mijovic T, Zeitouni A, Colmegna I. Autoimmune sensorineural hearing loss: the otology–rheumatology interface. Rheumatology (Oxford). 2013 May; 52(5):780-9. https://doi.org/10.1093/rheumatology/ket009
Murdin L, Patel S,Walmsley J, Hoe Yeoh L. Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol. 2008 May; 27(5): 637-40. https://doi.org/10.1007/s10067-007-0802-z
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2016 Ilham Rkain et al.
